Global Protein Characterization and Identification Market Overview

The Global Protein Characterization and Identification market was valued at USD 3.11 billion in 2023 and is expected to reach 6.26 billion by the year 2032, at a CAGR of 9.7%.

Protein characterization can be an extensive field of study covering an extensive range of analytical methods and techniques. Even though biochemists have made remarkable advances in protein analysis, the process of identifying and purifying novel proteins remains a forbidding task. This is largely owing to the scarcity of a universal solution for macromolecules with divergent aggregation states, structures, charges, and sizes. Proteins form the fundamental component of human life and therefore, they are an important subject of study and research. Furthermore, protein characterization and identification are the basic research process to analyze the contents of a protein based on its molecular weight and their charge. The requirements for protein characterization and identification are high for clinical diagnosis, agricultural and environmental research, and drug discovery and development.

The research process finds application over end-use sectors such as biotechnology, pharmaceutical, academic research institutes, and contract research organizations. The demand for protein characterization and identification is high for medical diagnosis, agricultural and ecological research, and drug detection and expansion. The research procedure finds application over end-use sections such as biotechnology, pharmaceutical, academic research institutes, and contract research organizations. 

COVID-19 Impact On Protein Characterization And Identification Market

Most industries over the globe have been poorly influenced over the last 18 months. This can be attributed to significant disruptions faced by their respective manufacturing and supply-chain operations as a result of various precautionary lockdowns, as well as other limitations that were executed by governing authorities over the world. The same applies to the global Protein Characterization and Identification market. Furthermore, consumer demand has also eventually declined as individuals are now determined on removing non-essential expenses from their respective budgets as the general economic status of most individuals has been severely influenced by this pandemic. These elements are anticipated to burden the revenue course of the global Protein Characterization and Identification market during the forecast period. Nevertheless, as respective governing authorities begin to lift these enforced lockdowns, the global Protein Characterization and Identification market is anticipated to regain accordingly. As the WHO officially declared the outbreak of COVID-19 a crisis, a mix of established pharmaceutical and biopharmaceutical companies have increased R&D and producing efforts to develop and distribute test kits, vaccines, and drugs against the SARS-CoV-2 virus. To accelerate the R&D process, many pharmaceutical and biotechnology companies teamed up with CROs through long-term agreements, collaborations and partnerships, over the world. For example, in January 2021, Avacta Group (UK) invaded a collaboration with Bruker Corporation (US) to estimate the bead-assisted mass spectrometry (BAMS) SARS-CoV-2 assay that the group produced with Adeptrix.

Market Dynamics And Factors For The Protein Characterization And Identification Market

Drivers:

To secure feasible growth, pharmaceutical and biotechnology companies are paying high attention to research and development activities. As a result, they are pouring large funds into such activities, which has a direct positive impact on the growth of the global protein characterization and identification market. In addition, the rising emphasis on drug discovery and development has favored the market for protein characterization and identification. Protein analysis is an important stage of pharma and biologic product development to identify potential candidates. Therefore, the drive to discover the latest and advanced drugs has received a significant enhancement with the acceptance of novel drug therapies. The resulting growth in R&D and expenditure will therefore favor the protein identification and characterization market. As per the Evaluate Pharma report, global pharmaceutical R&D spending was valued at USD 136 billion in 2012; this raised to USD 186 billion in 2019.

The vigorous growth of the biologics and proteomics sectors is also one of the major factors fueling the adoption of protein characterization and identification. Apart from this, different governments globally are investing large sums in proteomics research, which is providing a spur to the global protein characterization and identification market.

Restraints:

The excessive cost of instruments used in protein characterization and identification is playing a major obstacle to the growth of the market. Moreover, scarcity of knowledge about the right choice of technology and sample preparation also affects results and poses different direct and indirect expenses for end users.

Opportunities:

The Asia Pacific market is anticipated to provide growth opportunities for players due to the growing target of using protein analysis-based technologies for drug discovery, rising R&D initiatives to develop innovative proteomic and genomic techniques, different healthcare markets, and boosting research infrastructure. For example, In May 2021, Purolite declared a strategic collaboration with PharmNXT Biotech to cater Praesto mAb chromatography resin platform to South Korea and Singapore.

Market Segmentation

Segmentation Analysis of Protein Characterization and Identification Market:

Based on Product Type, the consumables segment is expected to register the maximum market share during the forecast period. Due to the rapid accessibility of a wide range of reagents and the requirement for reliable, specific, and rapid detection of diseases at the early stages. Moreover, tandem mass spectrometry forms the consumables segment is an efficient technique for the identification of peptides based on their fragmentation pattern (MS/MS scan). It can create individual spectra for each peptide, thereby creating a powerful tool for protein identification based on peptide characterization. This important advance in automatic data accession has enabled an efficient association between liquid chromatography and tandem mass spectrometry, and the use of nanocolumns and Nano electrospray ionization has compelling increased the efficiency of this method.

Based on Application, the drug discovery & development segment is expected to register the maximum market share during the forecast period. Due to the growing R&D expenditure and rising number of clinical trials for emerging developed therapeutics. Clinical trials take place in four distinct phases, the first three before the drug is marketed and the fourth phase begins when the pharmaceutical is prescribed for the first time and continues for the lifetime of the product.

Based on End-Users, the pharmaceutical & biotechnology companies segment dominated the market due to rising R&D expenditure of pharmaceutical and biotechnology companies and growing drug discovery activities. Disease processes, molecular compound tests, existing treatments with unanticipated effects, and the latest technologies trigger the drug discovery by the cycle.

Regional Analysis of Protein Characterization and Identification Market:

Asia Pacific region is expected to dominate the market for protein characterization and identification during the forecast period. The region is home to a large number of companies producing biotechnological analytical devices. The rising investments by governments of developing countries in research and development activities are heading to the greater uptake of protein electrophoresis equipment in the region. The expansion of APAC can also be attributed to the easy accessibility of raw materials and reagents. Japan and China will be key revenue backers to the growth of the protein characterization and identification market.

North America accounted for the largest share of the protein characterization and identification market, followed by Europe. The large share of the North American regional segment can be attributed to the accessibility of investment for innovative technologies from government organizations and the rising number of agreements and partnerships among large companies.

Europe will also represent a significant share in the protein characterization and identification market over the forecast period, with France and the U.K. being sights of high growth rate.

Players Covered in Protein Characterization and Identification Market are:

• General Electric Company (US)
• Cleaver Scientific (UK)
• Bio-Rad Laboratories Inc. (US)
• Merck KGaA (Germany)
• Danaher Corporation (US)
• Agilent Technologies Inc (US)
• Waters Corporation (US)
• Shimadzu Corporation (Japan)
• Creative Proteomics (US)
• PerkinElmer Inc. (the US)
• MS Bioworks (US)
• Rigaku Corporation (Japan)
• Analytik Jena (Germany)
• VProteomics (India)
• Promega Corporation (US)
• Bruker Corporation (US)
• Sartorius AG (Germany)
• HORIBA Ltd. (Japan)
• QIAGEN N.V. (Netherlands)
• Thermo Fisher Scientific Inc. (US)
• JEOL Ltd. (Japan)
• MassTech Inc. (US)
• Advion Inc. (the US)
• SERVA Electrophoresis GmbH (Germany)
• MilliporeSigma (US) and Other Major Players.

Key Industry Developments In Protein Characterization And Identification Market

• In February 2021, Thermo Fisher Scientific declared that the introduction of its flexible, online 2D-liquid chromatography (LC) systems. Thermo Scientific Vanquish Online 2D-Liquid Chromatography (LC) Systems provide a robust and flexible platform for environmental testing, pharmaceutical/biopharmaceutical R&D, food safety, omics, and polymer analysis scientists to characterize complex samples in-depth with the highest confidence.     
• In May 2021, Danaher Corporation and Waters Corporation joined hands to introduce Waters ultra-performance liquid chromatography instruments.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Product Type
 3.2 By Application
 3.3 By End-User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Protein Characterization And Identification Market by Product Type
 5.1 Protein Characterization And Identification Market Overview Snapshot and Growth Engine
 5.2 Protein Characterization And Identification Market Overview
 5.3 Consumables Immunoassay {Mass Spectrometry Consumables
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Consumables Immunoassay {Mass Spectrometry Consumables: Grographic Segmentation
 5.4 Chromatography Consumables
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Chromatography Consumables: Grographic Segmentation
 5.5 Electrophoresis Consumables
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Electrophoresis Consumables: Grographic Segmentation
 5.6 Others}
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Others}: Grographic Segmentation
 5.7 Instruments {Mass Spectrometry Instruments
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Instruments {Mass Spectrometry Instruments: Grographic Segmentation
 5.8 Chromatography Instruments
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size (2016-2028F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Chromatography Instruments: Grographic Segmentation
 5.9 Electrophoresis Instruments
  5.9.1 Introduction and Market Overview
  5.9.2 Historic and Forecasted Market Size (2016-2028F)
  5.9.3 Key Market Trends, Growth Factors and Opportunities
  5.9.4 Electrophoresis Instruments: Grographic Segmentation
 5.10 Others}
  5.10.1 Introduction and Market Overview
  5.10.2 Historic and Forecasted Market Size (2016-2028F)
  5.10.3 Key Market Trends, Growth Factors and Opportunities
  5.10.4 Others}: Grographic Segmentation
 5.11 Services
  5.11.1 Introduction and Market Overview
  5.11.2 Historic and Forecasted Market Size (2016-2028F)
  5.11.3 Key Market Trends, Growth Factors and Opportunities
  5.11.4 Services: Grographic Segmentation

Chapter 6: Protein Characterization And Identification Market by Application
 6.1 Protein Characterization And Identification Market Overview Snapshot and Growth Engine
 6.2 Protein Characterization And Identification Market Overview
 6.3 Drug Discovery & Development
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Drug Discovery & Development: Grographic Segmentation
 6.4 Clinical Diagnosis
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Clinical Diagnosis: Grographic Segmentation
 6.5 Other
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Other: Grographic Segmentation

Chapter 7: Protein Characterization And Identification Market by End-User
 7.1 Protein Characterization And Identification Market Overview Snapshot and Growth Engine
 7.2 Protein Characterization And Identification Market Overview
 7.3 Pharmaceutical & Biotechnology Companies
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Pharmaceutical & Biotechnology Companies: Grographic Segmentation
 7.4 Academic Research Institutions
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Academic Research Institutions: Grographic Segmentation
 7.5 Contract Research Organizations
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Contract Research Organizations: Grographic Segmentation
 7.6 Other
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Other: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Protein Characterization And Identification Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Protein Characterization And Identification Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Protein Characterization And Identification Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 GENERAL ELECTRIC COMPANY
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 CLEAVER SCIENTIFIC
 8.4 BIO-RAD LABORATORIES INC.
 8.5 MERCK KGAA
 8.6 DANAHER CORPORATION
 8.7 AGILENT TECHNOLOGIES INC
 8.8 WATERS CORPORATION
 8.9 SHIMADZU CORPORATION
 8.10 CREATIVE PROTEOMICS
 8.11 PERKINELMER INC.
 8.12 MS BIOWORKS
 8.13 RIGAKU CORPORATION
 8.14 ANALYTIK JENA
 8.15 VPROTEOMICS
 8.16 PROMEGA CORPORATION
 8.17 BRUKER CORPORATION
 8.18 SARTORIUS AG
 8.19 HORIBA LTD.
 8.20 QIAGEN N.V.
 8.21 THERMO FISHER SCIENTIFIC INC.
 8.22 JEOL LTD.
 8.23 MASSTECH INC.
 8.24 ADVION INC.
 8.25 SERVA ELECTROPHORESIS GMBH
 8.26 MILLIPORESIGMA
 8.27 OTHER MAJOR PLAYERS

Chapter 9: Global Protein Characterization And Identification Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Product Type
  9.2.1 Consumables Immunoassay {Mass Spectrometry Consumables
  9.2.2 Chromatography Consumables
  9.2.3 Electrophoresis Consumables
  9.2.4 Others}
  9.2.5 Instruments {Mass Spectrometry Instruments
  9.2.6 Chromatography Instruments
  9.2.7 Electrophoresis Instruments
  9.2.8 Others}
  9.2.9 Services
 9.3 Historic and Forecasted Market Size By Application
  9.3.1 Drug Discovery & Development
  9.3.2 Clinical Diagnosis
  9.3.3 Other
 9.4 Historic and Forecasted Market Size By End-User
  9.4.1 Pharmaceutical & Biotechnology Companies
  9.4.2 Academic Research Institutions
  9.4.3 Contract Research Organizations
  9.4.4 Other

Chapter 10: North America Protein Characterization And Identification Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Product Type
  10.4.1 Consumables Immunoassay {Mass Spectrometry Consumables
  10.4.2 Chromatography Consumables
  10.4.3 Electrophoresis Consumables
  10.4.4 Others}
  10.4.5 Instruments {Mass Spectrometry Instruments
  10.4.6 Chromatography Instruments
  10.4.7 Electrophoresis Instruments
  10.4.8 Others}
  10.4.9 Services
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Drug Discovery & Development
  10.5.2 Clinical Diagnosis
  10.5.3 Other
 10.6 Historic and Forecasted Market Size By End-User
  10.6.1 Pharmaceutical & Biotechnology Companies
  10.6.2 Academic Research Institutions
  10.6.3 Contract Research Organizations
  10.6.4 Other
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Protein Characterization And Identification Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Product Type
  11.4.1 Consumables Immunoassay {Mass Spectrometry Consumables
  11.4.2 Chromatography Consumables
  11.4.3 Electrophoresis Consumables
  11.4.4 Others}
  11.4.5 Instruments {Mass Spectrometry Instruments
  11.4.6 Chromatography Instruments
  11.4.7 Electrophoresis Instruments
  11.4.8 Others}
  11.4.9 Services
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Drug Discovery & Development
  11.5.2 Clinical Diagnosis
  11.5.3 Other
 11.6 Historic and Forecasted Market Size By End-User
  11.6.1 Pharmaceutical & Biotechnology Companies
  11.6.2 Academic Research Institutions
  11.6.3 Contract Research Organizations
  11.6.4 Other
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Protein Characterization And Identification Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Product Type
  12.4.1 Consumables Immunoassay {Mass Spectrometry Consumables
  12.4.2 Chromatography Consumables
  12.4.3 Electrophoresis Consumables
  12.4.4 Others}
  12.4.5 Instruments {Mass Spectrometry Instruments
  12.4.6 Chromatography Instruments
  12.4.7 Electrophoresis Instruments
  12.4.8 Others}
  12.4.9 Services
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Drug Discovery & Development
  12.5.2 Clinical Diagnosis
  12.5.3 Other
 12.6 Historic and Forecasted Market Size By End-User
  12.6.1 Pharmaceutical & Biotechnology Companies
  12.6.2 Academic Research Institutions
  12.6.3 Contract Research Organizations
  12.6.4 Other
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Protein Characterization And Identification Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Product Type
  13.4.1 Consumables Immunoassay {Mass Spectrometry Consumables
  13.4.2 Chromatography Consumables
  13.4.3 Electrophoresis Consumables
  13.4.4 Others}
  13.4.5 Instruments {Mass Spectrometry Instruments
  13.4.6 Chromatography Instruments
  13.4.7 Electrophoresis Instruments
  13.4.8 Others}
  13.4.9 Services
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Drug Discovery & Development
  13.5.2 Clinical Diagnosis
  13.5.3 Other
 13.6 Historic and Forecasted Market Size By End-User
  13.6.1 Pharmaceutical & Biotechnology Companies
  13.6.2 Academic Research Institutions
  13.6.3 Contract Research Organizations
  13.6.4 Other
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Protein Characterization And Identification Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Product Type
  14.4.1 Consumables Immunoassay {Mass Spectrometry Consumables
  14.4.2 Chromatography Consumables
  14.4.3 Electrophoresis Consumables
  14.4.4 Others}
  14.4.5 Instruments {Mass Spectrometry Instruments
  14.4.6 Chromatography Instruments
  14.4.7 Electrophoresis Instruments
  14.4.8 Others}
  14.4.9 Services
 14.5 Historic and Forecasted Market Size By Application
  14.5.1 Drug Discovery & Development
  14.5.2 Clinical Diagnosis
  14.5.3 Other
 14.6 Historic and Forecasted Market Size By End-User
  14.6.1 Pharmaceutical & Biotechnology Companies
  14.6.2 Academic Research Institutions
  14.6.3 Contract Research Organizations
  14.6.4 Other
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET COMPETITIVE RIVALRY
TABLE 005. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET THREAT OF NEW ENTRANTS
TABLE 006. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET THREAT OF SUBSTITUTES
TABLE 007. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET BY PRODUCT TYPE
TABLE 008. CONSUMABLES IMMUNOASSAY {MASS SPECTROMETRY CONSUMABLES MARKET OVERVIEW (2016-2028)
TABLE 009. CHROMATOGRAPHY CONSUMABLES MARKET OVERVIEW (2016-2028)
TABLE 010. ELECTROPHORESIS CONSUMABLES MARKET OVERVIEW (2016-2028)
TABLE 011. OTHERS} MARKET OVERVIEW (2016-2028)
TABLE 012. INSTRUMENTS {MASS SPECTROMETRY INSTRUMENTS MARKET OVERVIEW (2016-2028)
TABLE 013. CHROMATOGRAPHY INSTRUMENTS MARKET OVERVIEW (2016-2028)
TABLE 014. ELECTROPHORESIS INSTRUMENTS MARKET OVERVIEW (2016-2028)
TABLE 015. OTHERS} MARKET OVERVIEW (2016-2028)
TABLE 016. SERVICES MARKET OVERVIEW (2016-2028)
TABLE 017. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET BY APPLICATION
TABLE 018. DRUG DISCOVERY & DEVELOPMENT MARKET OVERVIEW (2016-2028)
TABLE 019. CLINICAL DIAGNOSIS MARKET OVERVIEW (2016-2028)
TABLE 020. OTHER MARKET OVERVIEW (2016-2028)
TABLE 021. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET BY END-USER
TABLE 022. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET OVERVIEW (2016-2028)
TABLE 023. ACADEMIC RESEARCH INSTITUTIONS MARKET OVERVIEW (2016-2028)
TABLE 024. CONTRACT RESEARCH ORGANIZATIONS MARKET OVERVIEW (2016-2028)
TABLE 025. OTHER MARKET OVERVIEW (2016-2028)
TABLE 026. NORTH AMERICA PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 027. NORTH AMERICA PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION (2016-2028)
TABLE 028. NORTH AMERICA PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END-USER (2016-2028)
TABLE 029. N PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY COUNTRY (2016-2028)
TABLE 030. EUROPE PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 031. EUROPE PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION (2016-2028)
TABLE 032. EUROPE PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END-USER (2016-2028)
TABLE 033. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY COUNTRY (2016-2028)
TABLE 034. ASIA PACIFIC PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 035. ASIA PACIFIC PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION (2016-2028)
TABLE 036. ASIA PACIFIC PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END-USER (2016-2028)
TABLE 037. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY COUNTRY (2016-2028)
TABLE 038. MIDDLE EAST & AFRICA PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 039. MIDDLE EAST & AFRICA PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION (2016-2028)
TABLE 040. MIDDLE EAST & AFRICA PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END-USER (2016-2028)
TABLE 041. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY COUNTRY (2016-2028)
TABLE 042. SOUTH AMERICA PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 043. SOUTH AMERICA PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY APPLICATION (2016-2028)
TABLE 044. SOUTH AMERICA PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY END-USER (2016-2028)
TABLE 045. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET, BY COUNTRY (2016-2028)
TABLE 046. GENERAL ELECTRIC COMPANY: SNAPSHOT
TABLE 047. GENERAL ELECTRIC COMPANY: BUSINESS PERFORMANCE
TABLE 048. GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO
TABLE 049. GENERAL ELECTRIC COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. CLEAVER SCIENTIFIC: SNAPSHOT
TABLE 050. CLEAVER SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 051. CLEAVER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 052. CLEAVER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. BIO-RAD LABORATORIES INC.: SNAPSHOT
TABLE 053. BIO-RAD LABORATORIES INC.: BUSINESS PERFORMANCE
TABLE 054. BIO-RAD LABORATORIES INC.: PRODUCT PORTFOLIO
TABLE 055. BIO-RAD LABORATORIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. MERCK KGAA: SNAPSHOT
TABLE 056. MERCK KGAA: BUSINESS PERFORMANCE
TABLE 057. MERCK KGAA: PRODUCT PORTFOLIO
TABLE 058. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. DANAHER CORPORATION: SNAPSHOT
TABLE 059. DANAHER CORPORATION: BUSINESS PERFORMANCE
TABLE 060. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 061. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. AGILENT TECHNOLOGIES INC: SNAPSHOT
TABLE 062. AGILENT TECHNOLOGIES INC: BUSINESS PERFORMANCE
TABLE 063. AGILENT TECHNOLOGIES INC: PRODUCT PORTFOLIO
TABLE 064. AGILENT TECHNOLOGIES INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. WATERS CORPORATION: SNAPSHOT
TABLE 065. WATERS CORPORATION: BUSINESS PERFORMANCE
TABLE 066. WATERS CORPORATION: PRODUCT PORTFOLIO
TABLE 067. WATERS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. SHIMADZU CORPORATION: SNAPSHOT
TABLE 068. SHIMADZU CORPORATION: BUSINESS PERFORMANCE
TABLE 069. SHIMADZU CORPORATION: PRODUCT PORTFOLIO
TABLE 070. SHIMADZU CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. CREATIVE PROTEOMICS: SNAPSHOT
TABLE 071. CREATIVE PROTEOMICS: BUSINESS PERFORMANCE
TABLE 072. CREATIVE PROTEOMICS: PRODUCT PORTFOLIO
TABLE 073. CREATIVE PROTEOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. PERKINELMER INC.: SNAPSHOT
TABLE 074. PERKINELMER INC.: BUSINESS PERFORMANCE
TABLE 075. PERKINELMER INC.: PRODUCT PORTFOLIO
TABLE 076. PERKINELMER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. MS BIOWORKS: SNAPSHOT
TABLE 077. MS BIOWORKS: BUSINESS PERFORMANCE
TABLE 078. MS BIOWORKS: PRODUCT PORTFOLIO
TABLE 079. MS BIOWORKS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. RIGAKU CORPORATION: SNAPSHOT
TABLE 080. RIGAKU CORPORATION: BUSINESS PERFORMANCE
TABLE 081. RIGAKU CORPORATION: PRODUCT PORTFOLIO
TABLE 082. RIGAKU CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. ANALYTIK JENA: SNAPSHOT
TABLE 083. ANALYTIK JENA: BUSINESS PERFORMANCE
TABLE 084. ANALYTIK JENA: PRODUCT PORTFOLIO
TABLE 085. ANALYTIK JENA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 085. VPROTEOMICS: SNAPSHOT
TABLE 086. VPROTEOMICS: BUSINESS PERFORMANCE
TABLE 087. VPROTEOMICS: PRODUCT PORTFOLIO
TABLE 088. VPROTEOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 088. PROMEGA CORPORATION: SNAPSHOT
TABLE 089. PROMEGA CORPORATION: BUSINESS PERFORMANCE
TABLE 090. PROMEGA CORPORATION: PRODUCT PORTFOLIO
TABLE 091. PROMEGA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 091. BRUKER CORPORATION: SNAPSHOT
TABLE 092. BRUKER CORPORATION: BUSINESS PERFORMANCE
TABLE 093. BRUKER CORPORATION: PRODUCT PORTFOLIO
TABLE 094. BRUKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 094. SARTORIUS AG: SNAPSHOT
TABLE 095. SARTORIUS AG: BUSINESS PERFORMANCE
TABLE 096. SARTORIUS AG: PRODUCT PORTFOLIO
TABLE 097. SARTORIUS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 097. HORIBA LTD.: SNAPSHOT
TABLE 098. HORIBA LTD.: BUSINESS PERFORMANCE
TABLE 099. HORIBA LTD.: PRODUCT PORTFOLIO
TABLE 100. HORIBA LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. QIAGEN N.V.: SNAPSHOT
TABLE 101. QIAGEN N.V.: BUSINESS PERFORMANCE
TABLE 102. QIAGEN N.V.: PRODUCT PORTFOLIO
TABLE 103. QIAGEN N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103. THERMO FISHER SCIENTIFIC INC.: SNAPSHOT
TABLE 104. THERMO FISHER SCIENTIFIC INC.: BUSINESS PERFORMANCE
TABLE 105. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 106. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. JEOL LTD.: SNAPSHOT
TABLE 107. JEOL LTD.: BUSINESS PERFORMANCE
TABLE 108. JEOL LTD.: PRODUCT PORTFOLIO
TABLE 109. JEOL LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 109. MASSTECH INC.: SNAPSHOT
TABLE 110. MASSTECH INC.: BUSINESS PERFORMANCE
TABLE 111. MASSTECH INC.: PRODUCT PORTFOLIO
TABLE 112. MASSTECH INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 112. ADVION INC.: SNAPSHOT
TABLE 113. ADVION INC.: BUSINESS PERFORMANCE
TABLE 114. ADVION INC.: PRODUCT PORTFOLIO
TABLE 115. ADVION INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115. SERVA ELECTROPHORESIS GMBH: SNAPSHOT
TABLE 116. SERVA ELECTROPHORESIS GMBH: BUSINESS PERFORMANCE
TABLE 117. SERVA ELECTROPHORESIS GMBH: PRODUCT PORTFOLIO
TABLE 118. SERVA ELECTROPHORESIS GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 118. MILLIPORESIGMA: SNAPSHOT
TABLE 119. MILLIPORESIGMA: BUSINESS PERFORMANCE
TABLE 120. MILLIPORESIGMA: PRODUCT PORTFOLIO
TABLE 121. MILLIPORESIGMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 121. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 122. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 123. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 124. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET OVERVIEW BY PRODUCT TYPE
FIGURE 012. CONSUMABLES IMMUNOASSAY {MASS SPECTROMETRY CONSUMABLES MARKET OVERVIEW (2016-2028)
FIGURE 013. CHROMATOGRAPHY CONSUMABLES MARKET OVERVIEW (2016-2028)
FIGURE 014. ELECTROPHORESIS CONSUMABLES MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHERS} MARKET OVERVIEW (2016-2028)
FIGURE 016. INSTRUMENTS {MASS SPECTROMETRY INSTRUMENTS MARKET OVERVIEW (2016-2028)
FIGURE 017. CHROMATOGRAPHY INSTRUMENTS MARKET OVERVIEW (2016-2028)
FIGURE 018. ELECTROPHORESIS INSTRUMENTS MARKET OVERVIEW (2016-2028)
FIGURE 019. OTHERS} MARKET OVERVIEW (2016-2028)
FIGURE 020. SERVICES MARKET OVERVIEW (2016-2028)
FIGURE 021. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET OVERVIEW BY APPLICATION
FIGURE 022. DRUG DISCOVERY & DEVELOPMENT MARKET OVERVIEW (2016-2028)
FIGURE 023. CLINICAL DIAGNOSIS MARKET OVERVIEW (2016-2028)
FIGURE 024. OTHER MARKET OVERVIEW (2016-2028)
FIGURE 025. PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET OVERVIEW BY END-USER
FIGURE 026. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET OVERVIEW (2016-2028)
FIGURE 027. ACADEMIC RESEARCH INSTITUTIONS MARKET OVERVIEW (2016-2028)
FIGURE 028. CONTRACT RESEARCH ORGANIZATIONS MARKET OVERVIEW (2016-2028)
FIGURE 029. OTHER MARKET OVERVIEW (2016-2028)
FIGURE 030. NORTH AMERICA PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 031. EUROPE PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 032. ASIA PACIFIC PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 033. MIDDLE EAST & AFRICA PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 034. SOUTH AMERICA PROTEIN CHARACTERIZATION AND IDENTIFICATION MARKET OVERVIEW BY COUNTRY (2016-2028)